Side-by-side comparison of AI visibility scores, market position, and capabilities
Boston global management consulting at $13.5B 2024 revenue (+10% YoY, 21st consecutive year); CEO Schweizer reelected Oct 2025 with BCG X 3,000-person tech division competing with McKinsey for Fortune 500 strategy mandates.
Boston Consulting Group (BCG) is a Boston, Massachusetts-headquartered global management consulting firm — the second-largest management consultancy globally by revenue, reporting $13.5 billion in revenue for 2024 (10% year-over-year growth, 21st consecutive year of growth) — employing 33,000+ professionals across 100+ offices in 50+ countries. BCG advises leaders across private sector, public sector, and social sector organizations on strategy, digital transformation, operational improvement, M&A, and organizational design. CEO Christoph Schweizer was reelected for a second four-year term beginning October 2025. BCG X, the firm's technology build-and-design division launched in 2022, employs nearly 3,000 technologists building software products and digital ventures for clients. Founded in 1963 by Bruce Henderson in Boston; BCG pioneered the Growth-Share Matrix (1970) and time-based competition frameworks that shaped modern strategic management.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.